Are you Dr. Wu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 26 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Yun Wu, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas and New York. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2003 - 2004
University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 1999 - 2003
Shanghai Medical UniversityClass of 1991
Certifications & Licensure
TX State Medical License 2003 - 2026
NY State Medical License 2002 - 2010- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- Impact of NOTCH1 expression in primary breast adenoid cystic carcinoma.Alireza Salem, Yun Wu, Qingqing Ding, Lavinia P Middleton> ;Journal of Clinical Pathology. 2024 Mar 12
- Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis.Suchko, M., Wen, J., Sun, H., Kang, E., Chen, H., Sweeney, K., Wu, Y., Krishnamurthy, S., Albarracin, C., Ding, Q., Foo, W., Sahin, A.> ;Breast Cancer Research and Treatment. 2024 Mar 5
- 1 citationsA Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland.Alireza Salem, Yun Wu, Constance T Albarracin, Lavinia P Middleton, Neda Kalhor, Yan Peng, Xiao Huang, Phyu P Aung, Hui Chen, Aysegul A Sahin, Qingqing Ding> ;Human Pathology. 2024 Mar 1
- Join now to see all
Press Mentions
Students Present Their Summer Research ProjectsSeptember 13th, 2021- AACR21 Preview: Discovery Science Driving Clinical BreakthroughsApril 5th, 2021
Sfrp1 Protects Against Acute Myocardial Ischemia (AMI) Injury in Aged Mice by Inhibiting the Wnt/Β-catenin Signaling PathwayJanuary 19th, 2021
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
